Table 1.
Demographics and nonpulmonary morbidities.
| All n = 147 | 2.0 ETT n = 69 | 2.5 ETT n = 78 | p-value | |
|---|---|---|---|---|
| Gestational Age, weeks; median (IQR) | 24 (23, 25) | 23 (22, 24) | 24 (24, 25) | <0.0001 |
| Birth weight, grams; median (IRQ) | 602 (502, 641) | 545 (450, 616) range 279, 737 | 648 (579, 700) range 463, 747 | <0.0001 |
| SGA, n, (%) | 11 (7%) | 5 (7.2%) | 6 (7.7%) | 0.9265 |
| Survived to discharge, n (%) | 121 (82%) | 53 (77%) | 68 (87%) | 0.0916 |
| Female sex, n (%) | 89 (61%) | 41 (59%) | 48 (62%) | 0.6245 |
| Race, n (%) | 0.8456 | |||
| Black | 23 (16%) | 11 (16%) | 12 (15%) | |
| Asian | 3 (2%) | 1 (1%) | 2 (3%) | |
| Hispanic, any race | 12 (8%) | 4 (6%) | 8 (10%) | |
| Multiracial | 25 (17%) | 13 (19%) | 12 (15%) | |
| White | 82 (56%) | 39 (57%) | 43 (55%) | |
| Antenatal steroids n, (%) | 142 (97%) | 66 (96%) | 76 (97%) | 1.0 |
| Length of stay, days, median (IQR) | 118 (81, 138) | 126 (80, 149) | 106 (84, 135) | 0.2073 |
| Intraventricular hemorrhage (IVH), n, (%) | 40 (27%) | 22 (31%) | 18 (23%) | 0.2392 |
| IVH grade 3 or 4, n, % | 20 (14%) | 14 (20%) | 6 (8%) | 0.02976 |
| Periventricular leukomalacia (PVL), n, % | 11/137 (8%) | 6/64 (9%) | 5/73 (7%) | 0.5873 |
| Postnatal steroids, n, % | 69/145 (48%) | 35/68 (51%) | 34/77 (44%) | 0.3788 |
| Sepsis, n, % | 38/144 (26%) | 20/69 (29%) | 18/75 (24%) | 0.4977 |